Dr. Alexander Clark Wiseman, MD

Dr. Wiseman practices at AdventHealth Porter in Denver, Colorado, part of AdventHealth.

Dr. Wiseman's NPI, 1033209713, was assigned on October 13, 2006. Dr. Wiseman graduated from Washington University School of Medicine in 1994. Dr. Wiseman holds Colorado license DR.0036734.

Dr. Wiseman's primary practice is AdventHealth Porter, at 2525 S Downing St, Denver, CO 80210 in Denver County. The practice phone is (303) 778-1955.

Dr. Wiseman's primary practice is AdventHealth Porter in Denver, Colorado, part of AdventHealth. Dr. Wiseman is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is AdventHealth Transplant Institute North Billings. Dmand AI also links Dr. Wiseman to 3 more hospitals and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wiseman practices, 6 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Wiseman's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Wiseman is licensed in Colorado.

CMS data shows 237 Medicare services from Dr. Wiseman across 3 procedure codes in 2024, for 82 Medicare patients. Medicare paid $24,892 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Wiseman in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 6.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wiseman's median patient age at 60, with 46% women.

In 2024, Dr. Wiseman wrote 699 Medicare Part D claims for 117 patients. 94% of them were for generic drugs. CMS names the drug for 559 of them, across 17 drugs with 11 or more claims each, at $42,177 in total drug cost. In 2023, CMS named 421 claims across 16 drugs.

Dr. Wiseman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wiseman as offering telehealth.

Dmand AI links 56 papers to Dr. Wiseman, published from 2010 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, Graft Survival and Graft Rejection. Dr. Wiseman has published most often in Am J Transplant. Dr. Wiseman's most frequent co-authors are Mona Devang Doshi, MD, Darshana M. Dadhania, MD and Erik J. Stites, MD.

Dmand AI links Dr. Wiseman to 5 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Viremia and Sepsis. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 2. Open Payments lists research payments to Dr. Wiseman that name 1 trial.

CMS Open Payments shows 182 general payments to Dr. Wiseman from 24 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 41% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $67,855. It also lists 9 research payments totaling $5,321 from 2017 to 2021, naming 1 clinical trial.

Dr. Wiseman graduated from Washington University School of Medicine in 1994.